Status:
RECRUITING
Assessment of CataClear, Tear Film Stability, Tear Volume, and Dry Eye Symptoms Using Stem Cells Fortified Eye Drops
Lead Sponsor:
Ace Cells Lab Limited
Collaborating Sponsors:
University of Nottingham
Conditions:
Dry Eye
Cataract
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Dry Eye Disease (DED) is a multifactorial condition that affects the ocular surface, leading to discomfort, tear film instability, and potential visual disturbances. Its global prevalence ranges betwe...
Detailed Description
Dry eye disease (DED) is a multifactorial condition affecting the ocular surface, characterized by symptoms of discomfort, visual disturbances, tear film instability, and potential damage to the ocula...
Eligibility Criteria
Inclusion
- Adults aged 18-80 years.
- Diagnosed with dry eye disease (based on clinical criteria such as OSDI scores and Schirmer test results).
Exclusion
Key Trial Info
Start Date :
April 22 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07191847
Start Date
April 22 2025
End Date
January 1 2026
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British center for regenerative medicine
Giza, Egypt, 335019